| IDEAL and the FDA |
Regulation, Commissioning, HTA and Policy. |
Danica Marinac-Dabic |
19 September, 2016 |
|
| MiCollar |
novel iPhone application to analyse cervical spine motion restriction with different size and type of cervical orthoses |
Rose Ingleton |
23 August, 2016 |
|
| Ethics of Surgical Innovation |
Explaining the views after being put into practice. |
Wendy Rogers |
15 August, 2016 |
|
| The merits of decision modelling in the IDEAL framework |
The case of innovative bilateral DIEP flap surgery. |
Janneke Grutters |
3 August, 2016 |
|
| Surgical Trainee Research Collaboratives in the UK |
An observational analysis of research activity and output. |
Angelos Kolias |
12 July, 2016 |
|
| Evaluation of HIFU ablation for uterine fibroids |
A multicenter IDEAL study. |
Joey Kwong |
7 July, 2016 |
|
| Perioperative Outcomes, Health Care Costs and Survival After Robotic-assisted Versus Open Radical Cystectomy |
A national comparative effectiveness study |
Bilal Chughtai |
6 July, 2016 |
|
| IDEAL Framework and Recommendations |
A template for device evaluation? |
Christopher Pennell |
6 July, 2016 |
|
| Applying IDEAL |
Early stage surgical innovation of a novel bio-wrap-assisted vasectomy reversal technique. |
Ahmet Gudeloglu |
6 July, 2016 |
|
| Small Simple Trials |
A Strategy to Study Rare Surgical Conditions. |
James Wright |
6 July, 2016 |
|
| Pilot and feasibility studies |
Methodological advances in evaluation. |
Gillian Lancaster |
6 July, 2016 |
|
| An innovative view on surgical research |
Evaluation surgical innovation of international examples |
Maroeska Rovers |
6 July, 2016 |
|
| Advancing the cause of Research Registration |
First 500 Registrations of the ResearchRegistry.com. |
Riaz Agha |
6 July, 2016 |
|
| Mind the Uncertainty Gap |
A comparative analysis of HTA of robotic surgery. |
Tammy Clifford |
6 July, 2016 |
|
| Is Buxton's Law still true? Evaluating evolving surgical techniques within pilot and full RCTs |
IDEAL surgical innovation in practice. |
Jane Blazeby |
27 June, 2016 |
|
| Transforming transplantation |
Organ preservation and reconditioning. |
Peter Friend |
27 June, 2016 |
|
| Is more evidence always better? |
The value of adding decision analytical modelling to the IDEAL framework |
Casper Tax |
27 June, 2016 |
|
| Progressing through IDEAL: When is the right time to move from observational to randomised studies? |
A case study of REBOA. |
Jan Jansen |
27 June, 2016 |
|
| Reconstruction of bladder defects with amniotic membrane |
Step 1-2 of IDEAL recommendations of surgical innovation |
David Barski |
27 June, 2016 |
|
| Using IDEAL within commissioning in the UK |
Regulation, Commissioning, HTA and Policy |
daphne austin |
21 June, 2016 |
|
| Optimising recruitment and evaluation: Qualitative studies |
Methodological advances in evaluation |
Jenny Donovan |
20 June, 2016 |
|
| Bringing evidence to the orthopaedic implant market |
We describe the challenges faced in the assessment of a novel surgical device, the X-Bolt, for the treatment of hip fractures from IDEAL stage 2a to 3. |
xavier griffin |
20 June, 2016 |
|
| Regulation of medical devices |
The application of the IDEAL framework through regulation, commission and policy. |
Art Sedrakyan |
7 June, 2016 |
|
| Developments in surgical innovation evaluation |
Evolving IDEAL |
Peter McCulloch |
7 June, 2016 |
|
